Skip to main content
Clinical Trials/NCT06312605
NCT06312605UnknownPhase 4

Patient Response and Recurrence Rate Following Adjunctive Intra-Mucosal or Topical Ascorbic Acid To Gingival Depigmentation Using Surgical Scalpel Technique: (Randomized Clinical and Histological Trial)

Ain Shams University1 site in 1 country24 target enrollmentStarted: August 1, 2023Last updated:
Conditions
Interventions

Trial Snapshot

Phase
Phase 4
Enrollment
24
Locations
1
Primary Endpoint
Pigmentation scores

Study Overview

Brief Summary

The goal of this clinical trial is to determine the role of vitamin C on recurrence of gingival pigment after patients who are healthy and esthetically concerned with it received surgical removal of this pigment. The main question[s] it aims to answer are:

  • Pigment recurrence after one year.
  • Patient satisfaction and histological response of tissues.

Participants will be asked to come on regular follow up visits one group will receive vitamin C injection other will be asked to apply topical vitamin C on a specific regimen.

Researcher will compare the groups who received injectable vitamin C with those who topically applied it to see the effect of each.

Detailed Description

Esthetic dentistry is currently concerned with the pivotal role of the gingival tissue along with the teeth color, shape and position to achieve a harmonious attractive smile.

Physiological gingival hyperpigmentation is attributed to the increased activity of melanocytes rather than the increased number; consequently the gingiva in these individuals reveals increased density of melanophores. There are several pigments that contribute to physiological gingival hyper pigmentation, the main contributory pigment is melanin that is synthesized by melanocytes. Melanocytes form melanosomes granules from the amino acid tyrosine converting it into a molecule called dehydroxyphenylalanine (DOPA) through a hydroxylation process catalyzed by tryosinase enzyme.

Surgical and non-surgical approaches have been utilized to treat gingival hyperpigmentation. De-epithelizing of the target region is the main concept for most of the surgical interventions using different techniques as de-epithelizing using surgical blade or bur abrasion, cryosurgery and laser.

Among the minimal invasive non-surgical approaches of treating gingival hyperpigmentation was vitamin C that yielded promising results in the previous few years as proved in different clinical trials and have been recently documented in systemic review by .Vitamin C binds to melanin effectively once introduced into the tissues with a consequent deficient in calcium and copper affecting both melanin formation and transportation.

One of the main challenges after treating gingival hyperpigmentation is pigment recurrence. Different theories tried to explain the reasons for recurrence, some attributed it to the three dimensional shape of rete pegs, others attributed it to the migration theory and capability of cells to migrate from existing neighboring areas . Recurrence of pigment had shown to be inevitable occurring with nearly equal ranges in the previously illustrated techniques.

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel
Primary Purpose
Treatment
Masking
Single (Outcomes Assessor)

Masking Description

Coding of the groups

Eligibility Criteria

Ages
18 Years to 40 Years (Adult)
Sex
All
Accepts Healthy Volunteers
Yes

Inclusion Criteria

  • •Both genders aged from 18-
  • •Systemically free patients from any disease as evidenced by the health questionnaire, using modified Cornell medical index and classified as ASA class I.
  • •Patients who were diagnosed to have physiological gingival melanin pigmentation on the maxillary or mandibular keratinized gingiva with Dummett oral pigmentation score 2 or more.
  • •Patients with thick gingival phenotype ≥ 1.5 mm.

Exclusion Criteria

  • •Pregnant or lactating females Smokers (water pipe, cigar or cigarette smoking). Patients taking or have taken any drug that may cause gingival depigmentation as chloroquine, minocycline, zidovudine, chlorpromazine, ketoconazole and bleomycin .
  • •Any cause for supplemental intake of vitamin C. Reported allergy to ascorbic acid or to any of its derivatives as reported in health questionnaire .
  • •Clinically diagnosed periodontitis regarding the following criteria probing depth >3mm, clinical attachment loss ≥ 1mm and bleeding on probing > 10% .
  • •Patients with poor oral hygiene, incompliant to treatment and persistence gingival inflammation after phase I periodontal therapy.

Arms & Interventions

Intramucosal vitamin C injection

Active Comparator

After surgical gingival depigmentation, injectable vitamin C (Redox C 500 mg) using insulin syringe(29 Gauge 1cc 0.33mm x 8mm 5/16 needle) is applied at gingival sites 0.1 ml for each point that should be 3 mm. The regimen is done once weekly for a month then once a month for additional 5 months.

Intervention: Injectable applied vitamin C (Procedure)

(Vitamin C topical gel

Active Comparator

After surgical gingival depigmentation, patients in this group apply ascorbic acid containing gel prepared by Nawah Scientific Research Center. The micro emulsion was prepared by mixing tween 20 (4.66% w/w) as surfactant and isopropanol (2.3% w/w) as co-surfactant using magnetic stirring then diluted drop-wise with Vitamin C solution in water (10% w/w). The formed micro emulsion was then converted into gel using Poloxamer 407 (20% w/w) that was added at 4°C under continuous magnetic stirring

Intervention: Topical applied Vitamin C (Procedure)

Control group

Placebo Comparator

Surgical gingival depigmentation is carried out for these patients

Intervention: Surgical depigmentation only (Procedure)

Outcomes

Primary Outcomes

Pigmentation scores

Time Frame: baseline (immediately before surgical depigmentation), one month, three months, six months, nine months and finally after 12 months post operatively

Dummet oral pigmentation index (DOPI) ,score (0-3), 0 = pink tissue \[no clinical pigmentation\]; 1 = mild light brown tissue \[mild clinical pigmentation\]; 2 = medium brown or mixed brown and pink tissue \[moderate clinical pigmentation\]; or 3 = deep brown/ blue-black tissue (heavy clinical pigmentation)

Assessment of pigment surface area (SA)

Time Frame: baseline (immediately before surgical depigmentation), one month, three months, six months, nine months and finally after 12 months post operatively

Standardized photos are taken and introduced into image J software after cropping interest area to calculate surface area of the pigment

Assessment of pigment intensity in terms of mean darkness value (MDV)

Time Frame: baseline (immediately before surgical depigmentation), one month, three months, six months, nine months and finally after 12 months post operatively

Standardized photos are taken and introduced into image J software after cropping interest area to calculate intensity of pigment

Secondary Outcomes

  • Patient satisfaction(After 12 months)
  • Histological response(baseline - 6 months -after a year)

Investigators

Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

Eman Osama Mohamed Hashem

Demonstrator at oral medicine and periodontology

Ain Shams University

Study Sites (1)

Loading locations...

Similar Trials